img

Global BCG Vaccine for Intradermal Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global BCG Vaccine for Intradermal Injection Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

BCG Vaccine for Intradermal Injection report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global BCG Vaccine for Intradermal Injection market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Hospital and Clinic are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for BCG Vaccine for Intradermal Injection industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, BCG Vaccine for Intradermal Injection key manufacturers include Merck, Sanofi Pasteur, Japan BCG Lab, Shanghai Institute of Biological Products, Serum Institute of India, Intervax and GSBPL, etc. Merck, Sanofi Pasteur, Japan BCG Lab are top 3 players and held % sales share in total in 2022.
BCG Vaccine for Intradermal Injection can be divided into BCG for Immunization and BCG for Therapy, etc. BCG for Immunization is the mainstream product in the market, accounting for % sales share globally in 2022.
BCG Vaccine for Intradermal Injection is widely used in various fields, such as Hospital, Clinic and Other,, etc. Hospital provides greatest supports to the BCG Vaccine for Intradermal Injection industry development. In 2022, global % sales of BCG Vaccine for Intradermal Injection went into Hospital filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global BCG Vaccine for Intradermal Injection market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Merck
Sanofi Pasteur
Japan BCG Lab
Shanghai Institute of Biological Products
Serum Institute of India
Intervax
GSBPL
Segment by Type
BCG for Immunization
BCG for Therapy

Segment by Application


Hospital
Clinic
Other

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the BCG Vaccine for Intradermal Injection market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of BCG Vaccine for Intradermal Injection, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the BCG Vaccine for Intradermal Injection industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of BCG Vaccine for Intradermal Injection in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, BCG Vaccine for Intradermal Injection introduction, etc. BCG Vaccine for Intradermal Injection Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of BCG Vaccine for Intradermal Injection market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 BCG Vaccine for Intradermal Injection Market Overview
1.1 BCG Vaccine for Intradermal Injection Product Overview
1.2 BCG Vaccine for Intradermal Injection Market Segment by Type
1.2.1 BCG for Immunization
1.2.2 BCG for Therapy
1.3 Global BCG Vaccine for Intradermal Injection Market Size by Type
1.3.1 Global BCG Vaccine for Intradermal Injection Market Size Overview by Type (2024-2034)
1.3.2 Global BCG Vaccine for Intradermal Injection Historic Market Size Review by Type (2024-2024)
1.3.3 Global BCG Vaccine for Intradermal Injection Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America BCG Vaccine for Intradermal Injection Sales Breakdown by Type (2024-2024)
1.4.2 Europe BCG Vaccine for Intradermal Injection Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific BCG Vaccine for Intradermal Injection Sales Breakdown by Type (2024-2024)
1.4.4 Latin America BCG Vaccine for Intradermal Injection Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa BCG Vaccine for Intradermal Injection Sales Breakdown by Type (2024-2024)
2 Global BCG Vaccine for Intradermal Injection Market Competition by Company
2.1 Global Top Players by BCG Vaccine for Intradermal Injection Sales (2024-2024)
2.2 Global Top Players by BCG Vaccine for Intradermal Injection Revenue (2024-2024)
2.3 Global Top Players by BCG Vaccine for Intradermal Injection Price (2024-2024)
2.4 Global Top Manufacturers BCG Vaccine for Intradermal Injection Manufacturing Base Distribution, Sales Area, Product Type
2.5 BCG Vaccine for Intradermal Injection Market Competitive Situation and Trends
2.5.1 BCG Vaccine for Intradermal Injection Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by BCG Vaccine for Intradermal Injection Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in BCG Vaccine for Intradermal Injection as of 2022)
2.7 Date of Key Manufacturers Enter into BCG Vaccine for Intradermal Injection Market
2.8 Key Manufacturers BCG Vaccine for Intradermal Injection Product Offered
2.9 Mergers & Acquisitions, Expansion
3 BCG Vaccine for Intradermal Injection Status and Outlook by Region
3.1 Global BCG Vaccine for Intradermal Injection Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global BCG Vaccine for Intradermal Injection Historic Market Size by Region
3.2.1 Global BCG Vaccine for Intradermal Injection Sales in Volume by Region (2024-2024)
3.2.2 Global BCG Vaccine for Intradermal Injection Sales in Value by Region (2024-2024)
3.2.3 Global BCG Vaccine for Intradermal Injection Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global BCG Vaccine for Intradermal Injection Forecasted Market Size by Region
3.3.1 Global BCG Vaccine for Intradermal Injection Sales in Volume by Region (2024-2034)
3.3.2 Global BCG Vaccine for Intradermal Injection Sales in Value by Region (2024-2034)
3.3.3 Global BCG Vaccine for Intradermal Injection Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global BCG Vaccine for Intradermal Injection by Application
4.1 BCG Vaccine for Intradermal Injection Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global BCG Vaccine for Intradermal Injection Market Size by Application
4.2.1 Global BCG Vaccine for Intradermal Injection Market Size Overview by Application (2024-2034)
4.2.2 Global BCG Vaccine for Intradermal Injection Historic Market Size Review by Application (2024-2024)
4.2.3 Global BCG Vaccine for Intradermal Injection Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America BCG Vaccine for Intradermal Injection Sales Breakdown by Application (2024-2024)
4.3.2 Europe BCG Vaccine for Intradermal Injection Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific BCG Vaccine for Intradermal Injection Sales Breakdown by Application (2024-2024)
4.3.4 Latin America BCG Vaccine for Intradermal Injection Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa BCG Vaccine for Intradermal Injection Sales Breakdown by Application (2024-2024)
5 North America BCG Vaccine for Intradermal Injection by Country
5.1 North America BCG Vaccine for Intradermal Injection Historic Market Size by Country
5.1.1 North America BCG Vaccine for Intradermal Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America BCG Vaccine for Intradermal Injection Sales in Volume by Country (2024-2024)
5.1.3 North America BCG Vaccine for Intradermal Injection Sales in Value by Country (2024-2024)
5.2 North America BCG Vaccine for Intradermal Injection Forecasted Market Size by Country
5.2.1 North America BCG Vaccine for Intradermal Injection Sales in Volume by Country (2024-2034)
5.2.2 North America BCG Vaccine for Intradermal Injection Sales in Value by Country (2024-2034)
6 Europe BCG Vaccine for Intradermal Injection by Country
6.1 Europe BCG Vaccine for Intradermal Injection Historic Market Size by Country
6.1.1 Europe BCG Vaccine for Intradermal Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe BCG Vaccine for Intradermal Injection Sales in Volume by Country (2024-2024)
6.1.3 Europe BCG Vaccine for Intradermal Injection Sales in Value by Country (2024-2024)
6.2 Europe BCG Vaccine for Intradermal Injection Forecasted Market Size by Country
6.2.1 Europe BCG Vaccine for Intradermal Injection Sales in Volume by Country (2024-2034)
6.2.2 Europe BCG Vaccine for Intradermal Injection Sales in Value by Country (2024-2034)
7 Asia-Pacific BCG Vaccine for Intradermal Injection by Region
7.1 Asia-Pacific BCG Vaccine for Intradermal Injection Historic Market Size by Region
7.1.1 Asia-Pacific BCG Vaccine for Intradermal Injection Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific BCG Vaccine for Intradermal Injection Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific BCG Vaccine for Intradermal Injection Sales in Value by Region (2024-2024)
7.2 Asia-Pacific BCG Vaccine for Intradermal Injection Forecasted Market Size by Region
7.2.1 Asia-Pacific BCG Vaccine for Intradermal Injection Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific BCG Vaccine for Intradermal Injection Sales in Value by Region (2024-2034)
8 Latin America BCG Vaccine for Intradermal Injection by Country
8.1 Latin America BCG Vaccine for Intradermal Injection Historic Market Size by Country
8.1.1 Latin America BCG Vaccine for Intradermal Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America BCG Vaccine for Intradermal Injection Sales in Volume by Country (2024-2024)
8.1.3 Latin America BCG Vaccine for Intradermal Injection Sales in Value by Country (2024-2024)
8.2 Latin America BCG Vaccine for Intradermal Injection Forecasted Market Size by Country
8.2.1 Latin America BCG Vaccine for Intradermal Injection Sales in Volume by Country (2024-2034)
8.2.2 Latin America BCG Vaccine for Intradermal Injection Sales in Value by Country (2024-2034)
9 Middle East and Africa BCG Vaccine for Intradermal Injection by Country
9.1 Middle East and Africa BCG Vaccine for Intradermal Injection Historic Market Size by Country
9.1.1 Middle East and Africa BCG Vaccine for Intradermal Injection Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa BCG Vaccine for Intradermal Injection Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa BCG Vaccine for Intradermal Injection Sales in Value by Country (2024-2024)
9.2 Middle East and Africa BCG Vaccine for Intradermal Injection Forecasted Market Size by Country
9.2.1 Middle East and Africa BCG Vaccine for Intradermal Injection Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa BCG Vaccine for Intradermal Injection Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Merck BCG Vaccine for Intradermal Injection Products Offered
10.1.5 Merck Recent Development
10.2 Sanofi Pasteur
10.2.1 Sanofi Pasteur Company Information
10.2.2 Sanofi Pasteur Introduction and Business Overview
10.2.3 Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Sanofi Pasteur BCG Vaccine for Intradermal Injection Products Offered
10.2.5 Sanofi Pasteur Recent Development
10.3 Japan BCG Lab
10.3.1 Japan BCG Lab Company Information
10.3.2 Japan BCG Lab Introduction and Business Overview
10.3.3 Japan BCG Lab BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
10.3.4 Japan BCG Lab BCG Vaccine for Intradermal Injection Products Offered
10.3.5 Japan BCG Lab Recent Development
10.4 Shanghai Institute of Biological Products
10.4.1 Shanghai Institute of Biological Products Company Information
10.4.2 Shanghai Institute of Biological Products Introduction and Business Overview
10.4.3 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Products Offered
10.4.5 Shanghai Institute of Biological Products Recent Development
10.5 Serum Institute of India
10.5.1 Serum Institute of India Company Information
10.5.2 Serum Institute of India Introduction and Business Overview
10.5.3 Serum Institute of India BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Serum Institute of India BCG Vaccine for Intradermal Injection Products Offered
10.5.5 Serum Institute of India Recent Development
10.6 Intervax
10.6.1 Intervax Company Information
10.6.2 Intervax Introduction and Business Overview
10.6.3 Intervax BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
10.6.4 Intervax BCG Vaccine for Intradermal Injection Products Offered
10.6.5 Intervax Recent Development
10.7 GSBPL
10.7.1 GSBPL Company Information
10.7.2 GSBPL Introduction and Business Overview
10.7.3 GSBPL BCG Vaccine for Intradermal Injection Sales, Revenue and Gross Margin (2024-2024)
10.7.4 GSBPL BCG Vaccine for Intradermal Injection Products Offered
10.7.5 GSBPL Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 BCG Vaccine for Intradermal Injection Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 BCG Vaccine for Intradermal Injection Industrial Chain Analysis
11.4 BCG Vaccine for Intradermal Injection Market Dynamics
11.4.1 BCG Vaccine for Intradermal Injection Industry Trends
11.4.2 BCG Vaccine for Intradermal Injection Market Drivers
11.4.3 BCG Vaccine for Intradermal Injection Market Challenges
11.4.4 BCG Vaccine for Intradermal Injection Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 BCG Vaccine for Intradermal Injection Distributors
12.3 BCG Vaccine for Intradermal Injection Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of BCG for Immunization
Table 2. Major Company of BCG for Therapy
Table 3. Global BCG Vaccine for Intradermal Injection Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 4. Global BCG Vaccine for Intradermal Injection Sales by Type (2024-2024) & (K Units)
Table 5. Global BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Type (2024-2024)
Table 6. Global BCG Vaccine for Intradermal Injection Sales by Type (2024-2024) & (US& Million)
Table 7. Global BCG Vaccine for Intradermal Injection Market Share in Value by Type (2024-2024)
Table 8. Global BCG Vaccine for Intradermal Injection Price by Type (2024-2024) & (US$/Unit)
Table 9. Global BCG Vaccine for Intradermal Injection Sales by Type (2024-2034) & (K Units)
Table 10. Global BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Type (2024-2034)
Table 11. Global BCG Vaccine for Intradermal Injection Sales by Type (2024-2034) & (US$ Million)
Table 12. Global BCG Vaccine for Intradermal Injection Sales Market Share in Value by Type (2024-2034)
Table 13. Global BCG Vaccine for Intradermal Injection Price by Type (2024-2034) & (US$/Unit)
Table 14. North America BCG Vaccine for Intradermal Injection Sales by Type (2024-2024) & (K Units)
Table 15. North America BCG Vaccine for Intradermal Injection Sales by Type (2024-2024) & (US$ Million)
Table 16. Europe BCG Vaccine for Intradermal Injection Sales (K Units) by Type (2024-2024)
Table 17. Europe BCG Vaccine for Intradermal Injection Sales by Type (2024-2024) & (US$ Million)
Table 18. Asia-Pacific BCG Vaccine for Intradermal Injection Sales (K Units) by Type (2024-2024)
Table 19. Asia-Pacific BCG Vaccine for Intradermal Injection Sales by Type (2024-2024) & (US$ Million)
Table 20. Latin America BCG Vaccine for Intradermal Injection Sales (K Units) by Type (2024-2024)
Table 21. Latin America BCG Vaccine for Intradermal Injection Sales by Type (2024-2024) & (US$ Million)
Table 22. Middle East and Africa BCG Vaccine for Intradermal Injection Sales (K Units) by Type (2024-2024)
Table 23. Middle East and Africa BCG Vaccine for Intradermal Injection Sales by Type (2024-2024) & (US$ Million)
Table 24. Global BCG Vaccine for Intradermal Injection Sales by Company (2024-2024) & (K Units)
Table 25. Global BCG Vaccine for Intradermal Injection Sales Share by Company (2024-2024)
Table 26. Global BCG Vaccine for Intradermal Injection Revenue by Company (2024-2024) & (US$ Million)
Table 27. Global BCG Vaccine for Intradermal Injection Revenue Share by Company (2024-2024)
Table 28. Global Market BCG Vaccine for Intradermal Injection Price by Company (2024-2024) & (US$/Unit)
Table 29. Global BCG Vaccine for Intradermal Injection Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global BCG Vaccine for Intradermal Injection Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in BCG Vaccine for Intradermal Injection as of 2022)
Table 32. Date of Key Manufacturers Enter into BCG Vaccine for Intradermal Injection Market
Table 33. Key Manufacturers BCG Vaccine for Intradermal Injection Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global BCG Vaccine for Intradermal Injection Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 36. Global BCG Vaccine for Intradermal Injection Sales by Region (2024-2024) & (K Units)
Table 37. Global BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Region (2024-2024)
Table 38. Global BCG Vaccine for Intradermal Injection Sales by Region (2024-2024) & (US$ Million)
Table 39. Global BCG Vaccine for Intradermal Injection Sales Market Share in Value by Region (2024-2024)
Table 40. Global BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2024)
Table 41. Global BCG Vaccine for Intradermal Injection Sales by Region (2024-2034) & (K Units)
Table 42. Global BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Region (2024-2034)
Table 43. Global BCG Vaccine for Intradermal Injection Sales by Region (2024-2034) & (US$ Million)
Table 44. Global BCG Vaccine for Intradermal Injection Sales Market Share in Value by Region (2024-2034)
Table 45. Global BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global BCG Vaccine for Intradermal Injection Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 47. Global BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) & (K Units)
Table 48. Global BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Application (2024-2024)
Table 49. Global BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) & (US$ Million)
Table 50. Global BCG Vaccine for Intradermal Injection Sales Market Share in Value by Application (2024-2024)
Table 51. Global BCG Vaccine for Intradermal Injection Price by Application (2024-2024) & (US$/Unit)
Table 52. Global BCG Vaccine for Intradermal Injection Sales by Application (2024-2034) & (K Units)
Table 53. Global BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Application (2024-2034)
Table 54. Global BCG Vaccine for Intradermal Injection Sales by Application (2024-2034) & (US$ Million)
Table 55. Global BCG Vaccine for Intradermal Injection Sales Market Share in Value by Application (2024-2034)
Table 56. Global BCG Vaccine for Intradermal Injection Price by Application (2024-2034) & (US$/Unit)
Table 57. North America BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) (K Units)
Table 58. North America BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) & (US$ Million)
Table 59. Europe BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) (K Units)
Table 60. Europe BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) & (US$ Million)
Table 61. Asia-Pacific BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) (K Units)
Table 62. Asia-Pacific BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) & (US$ Million)
Table 63. Latin America BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) (K Units)
Table 64. Latin America BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) & (US$ Million)
Table 65. Middle East and Africa BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) (K Units)
Table 66. Middle East and Africa BCG Vaccine for Intradermal Injection Sales by Application (2024-2024) & (US$ Million)
Table 67. North America BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (K Units)
Table 68. North America BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Country (2024-2024)
Table 69. North America BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (US$ Million)
Table 70. North America BCG Vaccine for Intradermal Injection Sales Market Share in Value by Country (2024-2024)
Table 71. North America BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (K Units)
Table 72. North America BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Country (2024-2034)
Table 73. North America BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (US$ Million)
Table 74. North America BCG Vaccine for Intradermal Injection Sales Market Share in Value by Country (2024-2034)
Table 75. Europe BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (K Units)
Table 76. Europe BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Country (2024-2024)
Table 77. Europe BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (US$ Million)
Table 78. Europe BCG Vaccine for Intradermal Injection Sales Market Share in Value by Country (2024-2024)
Table 79. Europe BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (K Units)
Table 80. Europe BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe BCG Vaccine for Intradermal Injection Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific BCG Vaccine for Intradermal Injection Sales by Region (2024-2024) & (K Units)
Table 84. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Region (2024-2024)
Table 85. Asia-Pacific BCG Vaccine for Intradermal Injection Sales by Region (2024-2024) & (US$ Million)
Table 86. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Market Share in Value by Region (2024-2024)
Table 87. Asia-Pacific BCG Vaccine for Intradermal Injection Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific BCG Vaccine for Intradermal Injection Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (K Units)
Table 92. Latin America BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Country (2024-2024)
Table 93. Latin America BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (US$ Million)
Table 94. Latin America BCG Vaccine for Intradermal Injection Sales Market Share in Value by Country (2024-2024)
Table 95. Latin America BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (K Units)
Table 96. Latin America BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America BCG Vaccine for Intradermal Injection Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (K Units)
Table 100. Middle East and Africa BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Country (2024-2024)
Table 101. Middle East and Africa BCG Vaccine for Intradermal Injection Sales by Country (2024-2024) & (US$ Million)
Table 102. Middle East and Africa BCG Vaccine for Intradermal Injection Sales Market Share in Value by Country (2024-2024)
Table 103. Middle East and Africa BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa BCG Vaccine for Intradermal Injection Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa BCG Vaccine for Intradermal Injection Sales Market Share in Value by Country (2024-2034)
Table 107. Merck Company Information
Table 108. Merck Introduction and Business Overview
Table 109. Merck BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 110. Merck BCG Vaccine for Intradermal Injection Product
Table 111. Merck Recent Development
Table 112. Sanofi Pasteur Company Information
Table 113. Sanofi Pasteur Introduction and Business Overview
Table 114. Sanofi Pasteur BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 115. Sanofi Pasteur BCG Vaccine for Intradermal Injection Product
Table 116. Sanofi Pasteur Recent Development
Table 117. Japan BCG Lab Company Information
Table 118. Japan BCG Lab Introduction and Business Overview
Table 119. Japan BCG Lab BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 120. Japan BCG Lab BCG Vaccine for Intradermal Injection Product
Table 121. Japan BCG Lab Recent Development
Table 122. Shanghai Institute of Biological Products Company Information
Table 123. Shanghai Institute of Biological Products Introduction and Business Overview
Table 124. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 125. Shanghai Institute of Biological Products BCG Vaccine for Intradermal Injection Product
Table 126. Shanghai Institute of Biological Products Recent Development
Table 127. Serum Institute of India Company Information
Table 128. Serum Institute of India Introduction and Business Overview
Table 129. Serum Institute of India BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 130. Serum Institute of India BCG Vaccine for Intradermal Injection Product
Table 131. Serum Institute of India Recent Development
Table 132. Intervax Company Information
Table 133. Intervax Introduction and Business Overview
Table 134. Intervax BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 135. Intervax BCG Vaccine for Intradermal Injection Product
Table 136. Intervax Recent Development
Table 137. GSBPL Company Information
Table 138. GSBPL Introduction and Business Overview
Table 139. GSBPL BCG Vaccine for Intradermal Injection Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2024-2024)
Table 140. GSBPL BCG Vaccine for Intradermal Injection Product
Table 141. GSBPL Recent Development
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. BCG Vaccine for Intradermal Injection Market Trends
Table 145. BCG Vaccine for Intradermal Injection Market Drivers
Table 146. BCG Vaccine for Intradermal Injection Market Challenges
Table 147. BCG Vaccine for Intradermal Injection Market Restraints
Table 148. BCG Vaccine for Intradermal Injection Distributors List
Table 149. BCG Vaccine for Intradermal Injection Downstream Customers
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. BCG Vaccine for Intradermal Injection Product Picture
Figure 2. Global BCG Vaccine for Intradermal Injection Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global BCG Vaccine for Intradermal Injection Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global BCG Vaccine for Intradermal Injection Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of BCG for Immunization
Figure 6. Global BCG for Immunization Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of BCG for Therapy
Figure 8. Global BCG for Therapy Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Global BCG Vaccine for Intradermal Injection Sales by Type (2024-2034) & (US$ Million)
Figure 10. Global BCG Vaccine for Intradermal Injection Sales Market Share by Type in 2022 & 2034
Figure 11. North America BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Type in 2022
Figure 12. North America BCG Vaccine for Intradermal Injection Sales Market Share in Value by Type in 2022
Figure 13. Europe BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Type in 2022
Figure 14. Europe BCG Vaccine for Intradermal Injection Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Market Share in Value by Type in 2022
Figure 17. Latin America BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Type in 2022
Figure 18. Latin America BCG Vaccine for Intradermal Injection Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa BCG Vaccine for Intradermal Injection Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by BCG Vaccine for Intradermal Injection Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by BCG Vaccine for Intradermal Injection Revenue in 2022
Figure 23. BCG Vaccine for Intradermal Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2024-2034) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2024-2034) & (K Units)
Figure 28. Product Picture of Other
Figure 29. Global Other Sales YoY Growth (2024-2034) & (K Units)
Figure 30. Global BCG Vaccine for Intradermal Injection Sales by Application (2024-2034) & (US$ Million)
Figure 31. Global BCG Vaccine for Intradermal Injection Sales Market Share by Application in 2022 & 2034
Figure 32. North America BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Application in 2022
Figure 33. North America BCG Vaccine for Intradermal Injection Sales Market Share in Value by Application in 2022
Figure 34. Europe BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Application in 2022
Figure 35. Europe BCG Vaccine for Intradermal Injection Sales Market Share in Value by Application in 2022
Figure 36. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Application in 2022
Figure 37. Asia-Pacific BCG Vaccine for Intradermal Injection Sales Market Share in Value by Application in 2022
Figure 38. Latin America BCG Vaccine for Intradermal Injection Sales Market Share in Volume by Application in 2022
Figure 39. Latin America BCG Vaccine for Intradermal Injection Sales Market Share in Value by Application in 2022
Figure 40. Middle East and Africa BCG Vaccine for Intradermal Injection Sales Market Share in Value by Application in 2022
Figure 41. Key Raw Materials Price
Figure 42. BCG Vaccine for Intradermal Injection Manufacturing Cost Structure
Figure 43. BCG Vaccine for Intradermal Injection Industrial Chain Analysis
Figure 44. Channels of Distribution
Figure 45. Distributors Profiles
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed